Insight

Pasquale Pisapia: The relevance of the reference range for EGFR testing in non-small cell lung cancer patients

Pasquale Pisapia/X

Nov 14, 2024, 15:41

Pasquale Pisapia: The relevance of the reference range for EGFR testing in non-small cell lung cancer patients

Pasquale Pisapia, Associate Editor section “Oncology” at Heliyon, shared a post on X:

“Thrilled to share our paper entitled ‘The relevance of the reference range for EGFR testing in non-small cell lung cancer patients’ on Lung Cancer Journal.”

Pasquale Pisapia

The relevance of the reference range for EGFR testing in non-small cell lung cancer patients.

Authors: Pasquale Pisapiaa, Alessandro Russob, Caterina De Lucaa, Francesco Pepea, Francesco Dragoa, Christian Rolfoc, Giancarlo Troncone

Pasquale Pisapia

Alessandro Russob cancer Caterina De Lucaa Christian Rolfoc EGFR testing Francesco Dragoa Francesco Pepea Giancarlo Troncone Lung Cancer Journal OncoDaily Oncology Pasquale Pisapia Pasquale Pisapiaa small cell lung cancer

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer